Curetis Announces New Supervisory Board of Curetis N.V.
October 29, 2015 09:30 ET
|
Curetis AG
AMSTERDAM, The Netherlands and HOLZGERLINGEN, Germany, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Curetis B.V.1 ("Curetis"), a developer of next-level molecular diagnostic solutions, today announced the...
Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution
October 05, 2015 11:00 ET
|
Curetis AG
Curetis licenses Acumen's proprietary sepsis biomarker panel for use with Unyvero Platform
Diagnostics Development (DxD) Hub in Singapore to support Acumen in development and clinical...
Curetis Enters Into Distribution Agreement to Expand Commercial Activities Into Greater China
September 25, 2015 09:30 ET
|
Curetis AG
Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan
Clinical trials for CFDA regulatory approval in...
Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections
July 08, 2015 10:39 ET
|
Curetis AG
First patient enrolled in prospective arm of IVD trial
Study to include a total of at least 2,500 patient samples
Milestone triggers payment of EUR 6.8 million financing...
Curetis' Unyvero System Selected for Global Phase III Antibiotics Trial
June 24, 2015 09:56 ET
|
Curetis AG
HOLZGERLINGEN, Germany, June 24, 2015 (GLOBE NEWSWIRE) -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that Curetis' Unyvero System will be used in a Phase III...
Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer
May 11, 2015 09:30 ET
|
Curetis AG
HOLZGERLINGEN, Germany, May 11, 2015 (GLOBE NEWSWIRE) -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced Dr. Achim Plum has been appointed to the newly-created...
Curetis Expands Commercial Organization
April 20, 2015 09:30 ET
|
Curetis AG
Augmented direct sales force, led by new Head of International Sales, to broaden reach in key European markets
New distribution partnerships in Italy and Middle East
HOLZGERLINGEN, Germany,...
Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015
April 16, 2015 09:30 ET
|
Curetis AG
- Company Successfully Completes Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application
- Clinical sensitivity across 40-marker panel averages 94% at 99.4% specificity...